FlexiMed: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FlexiMed
Largest movements
- Receivables within one year -€19,294
down €19,294 (-92.8%), from €20,795 to €1,502
of which Trade receivables: -€17,896
- Cash +€774
up €774 (+15.0%), from €5,170 to €5,944
mainly Receivables within one year (+€19,294) and Other debts (+€8,016)
- Trade debts -€19,184
down €19,184 (-87.6%), from €21,892 to €2,708
- Profit (loss) carried forward -€9,775
down €9,775 (-7.6%), from -€128,462 to -€138,237
- Other debts +€8,016
up €8,016 (+8.0%), from €100,558 to €108,573
- Tax, wage and social debts +€2,424
new in 2025: €2,424
- Gross operating margin +€108,412
up €108,412 (+92.2%), from -€117,617 to -€9,205
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €28,237 | €9,718 | -€18,520 | -65.6% |
| Current assets | 29/58 | €28,237 | €9,718 | -€18,520 | -65.6% |
| Amounts receivable within one year | 40/41 | €20,795 | €1,502 | -€19,294 | -92.8% |
| Trade receivables | 40 | €19,398 | €1,502 | -€17,896 | -92.3% |
| Other amounts receivable | 41 | €1,397 | €0 | -€1,397 | -100.0% |
| Cash at bank and in hand | 54/58 | €5,170 | €5,944 | +€774 | +15.0% |
| Deferred charges and accrued income | 490/1 | €2,272 | €2,272 | = | 0.0% |
| Total equity and liabilities | 10/49 | €28,237 | €9,718 | -€18,520 | -65.6% |
| Equity | 10/15 | -€123,462 | -€133,237 | -€9,775 | -7.9% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€128,462 | -€138,237 | -€9,775 | -7.6% |
| Amounts payable | 17/49 | €151,700 | €142,955 | -€8,745 | -5.8% |
| Amounts payable after more than one year | 17 | €29,250 | €29,250 | = | 0.0% |
| Other amounts payable | 178/9 | €29,250 | €29,250 | = | 0.0% |
| Amounts payable within one year | 42/48 | €122,450 | €113,705 | -€8,745 | -7.1% |
| Trade debts | 44 | €21,892 | €2,708 | -€19,184 | -87.6% |
| Suppliers | 440/4 | €21,892 | €2,708 | -€19,184 | -87.6% |
| Taxes, remuneration and social security | 45 | - | €2,424 | +€2,424 | |
| Taxes | 450/3 | - | €2,424 | +€2,424 | |
| Other amounts payable | 47/48 | €100,558 | €108,573 | +€8,016 | +8.0% |
| Other operating charges | 640/8 | €451 | €473 | +€22 | +4.9% |
| Gross operating margin | 9900 | -€117,617 | -€9,205 | +€108,412 | +92.2% |
| Operating profit (loss) | 9901 | -€118,068 | -€9,678 | +€108,390 | +91.8% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €54 | €97 | +€43 | +78.8% |
| Recurring financial charges | 65 | €54 | €97 | +€43 | +78.8% |
| Profit (loss) for the period before taxes | 9903 | -€118,122 | -€9,775 | +€108,348 | +91.7% |
| Profit (loss) for the period | 9904 | -€118,122 | -€9,775 | +€108,348 | +91.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€118,122 | -€9,775 | +€108,348 | +91.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.